At the National Library of Medicine (NLM), we’ve been working on multiple fronts to improve researchers’ understanding of SARS-CoV-2 (the virus that causes coronavirus disease, or COVID-19) and aid in the response to COVID-19. By enhancing access to relevant data and information, NLM is demonstrating how libraries can contribute in real time to research and response efforts during this crisis.

 

NLM Director's COVID-19 Updates

Dr. Patricia Flatley Brennan, the Director of NLM, has used her blog, Musings from the Mezzanine to keep the community up to date on how NLM has responded to the pandemic. Some of her COVID-19-related blog posts include:

Emergency Funding Allows NLM to Expand COVID-19 Research and Services

How Does a Library Respond to a Global Health Crisis?

NIH One Step Closer to Speeding Delivery of COVID-19 Testing Technologies to Those Who Need It Most Through RADx-Up

LitCovid

NLM created LitCovid, which is a curated literature hub for tracking up-to-date scientific information about COVID-19. Watch the video below to learn how LitCovid works and the types of information it is collecting.

SRA and GenBank

Learn about Sequence Read Archive (SRA) & GenBank, two open access databases critical in the fight against COVID-19.

NLM COVID-19 Web Archive

NLM is archiving web and social media content documenting the COVID-19 outbreak as part of the Library’s ongoing Global Health Events web archive collection. Read this Circulating Now blog post to learn more.

National Center for Biotechnology Information (NCBI) SARS-CoV-2 Resources

Get comprehensive access to NLM’s literature, sequence, and clinical resource information on the NCBI SARS-CoV-2 Resources page.

PubMed Journal Articles

Explore journal articles on COVID-19 on PubMed, NLM's free resource supporting the search and retrieval of biomedical and life sciences literature.

ClinicalTrials.gov

ClinicalTrials.gov created an easy way to find COVID-19-related clinical trials with just one click.

NIH Preprints Pilot

The NIH Preprint Pilot is intended to increase early discoverability of NIH-supported research results, maximizing the possible impact of the research.